Schense J C, Bloch J, Aebischer P, Hubbell J A
Department of Materials and Institute for Biomedical Engineering, ETH-Zurich and the University of Zurich, Zurich, Switzerland.
Nat Biotechnol. 2000 Apr;18(4):415-9. doi: 10.1038/74473.
Fibrin plays an important role in wound healing and regeneration, and enjoys widespread use in surgery and tissue engineering. The enzymatic activity of Factor XIIIa was employed to covalently incorporate exogenous bioactive peptides within fibrin during coagulation. Fibrin gels were formed with incorporated peptides from laminin and N-cadherin alone and in combination at concentrations up to 8.2 mol peptide per mole of fibrinogen. Neurite extension in vitro was enhanced when gels were augmented with exogenous peptide, with the maximal improvement reaching 75%. When this particular fibrin derivative was evaluated in rats in the repair of the severed dorsal root within polymeric tubes, the number of regenerated axons was enhanced by 85% relative to animals treated with tubes filled with unmodified fibrin. These results demonstrate that it is possible to enhance the biological activity of fibrin by enzymatically incorporating exogenous oligopeptide domains of morphoregulatory proteins.
纤维蛋白在伤口愈合和再生中发挥着重要作用,并且在外科手术和组织工程中得到广泛应用。在凝血过程中,利用凝血因子ⅩⅢa的酶活性将外源性生物活性肽共价结合到纤维蛋白中。单独以及联合使用层粘连蛋白和N-钙黏蛋白的肽段,以每摩尔纤维蛋白原最高达8.2摩尔肽的浓度形成了含有掺入肽段的纤维蛋白凝胶。当凝胶添加外源性肽时,体外神经突延伸得到增强,最大改善幅度达到75%。当在大鼠体内评估这种特定的纤维蛋白衍生物在聚合物管内修复切断的背根时,相对于用填充未修饰纤维蛋白的管子治疗的动物,再生轴突的数量增加了85%。这些结果表明,通过酶促掺入形态调节蛋白的外源性寡肽结构域来增强纤维蛋白的生物活性是可能的。